Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy is a research paper published in Journal of the American Heart Association (2020). On theSindex it has a DataRank of 1.9. It has been cited 65 times, with 52 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.628
From this paper's citation signal
Citation Network Contribution
1.2
From 38 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 52 citers.
MeSH Terms
Keywords
Additional file 1 of Plasma ceramides as biomarkers for microvascular disease and clinical outcomes in diabetes and myocardial infarction
Additional file 1 of Plasma ceramides as biomarkers for microvascular disease and clinical outcomes in diabetes and myocardial infarction